Global Viral Conjunctivitis Drugs Market 2016-2020

Table of Contents

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Disease overview

• Conjunctivitis
• Viral conjunctivitis
• Signs and symptoms
• Diagnosis
• Management
• Epidemiology
• Economic burden

PART 06: Pipeline analysis

• FST-100
• APD-209 eye drops
• SPL7013
• EKC-Cide
• PP-001

PART 07: Market landscape

• Market overview
• Market size and forecast
• Viral conjunctivitis drugs market in US
• Five forces analysis

PART 08: Market segmentation by route of administration

• Topical
• Oral
• Intravitreal

PART 09: Geographical segmentation

• Global viral conjunctivitis drugs market by geography 2015-2020
• Viral conjunctivitis drugs market in Americas
• Viral conjunctivitis drugs market in EMEA
• Viral conjunctivitis drugs market in APAC

PART 10: Market drivers

• Rising awareness
• Unmet needs for viral conjunctivitis
• High prevalence

PART 11: Impact of drivers

PART 12: Market challenges

• Low diagnosis rate
• Adverse effects and limited efficacy of drugs
• Satisfaction with existing therapies
• Availability of alternative therapies

PART 13: Impact of drivers and challenges

PART 14: Market trends

• Strategic alliances and M&A
• Use of off-label drugs
• Rise in R&D

PART 15: Vendor landscape

• Akorn
• Alcon
• Allergan
• Bausch & Lomb
• Other prominent vendors

PART 16: Appendix

• List of abbreviations

PART 17: Explore Technavio